URIGEN PHARMACEUTICALS, INC.
675 Highway One
B-206
North Brunswick, NJ 08902
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Urigen Pharmaceuticals, Inc. |
Registration Statement on Form S-1
Filed February 11, 2015
File No. 333-202034
Ladies and Gentlemen:
Urigen Pharmaceuticals, Inc. (the "Registrant") previously filed the above-referenced registration statement on Form S-1 (the "Registration Statement"). Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, the Registrant hereby requests that the Registration Statement, together with all exhibits and amendments thereto, be withdrawn at your earliest convenience.
The Registration Statement was never declared effective. The Registrant believes withdrawal of the Registration Statement to be consistent with the public interest and the protection of investors. The Registrant represents that no securities have been sold pursuant to the Registration Statement.
If you have any questions about this withdrawal request, please contact Tahra Wright of Loeb & Loeb at (212) 407-4122.
Sincerely,
/s/ Mark J. Rosenblum
Mark J. Rosenblum
Chief Financial Officer
May 1, 2015
